Malaria Drug Could Combat Head and Neck Cancer Chemotherapy Resistance - Genetic Engineering & Biotechnology News

Hydroxychloroquine inhibited pathways that drive cisplatin resistance and restored tumor-killing effects of chemotherapy in animal models of SCCHN.

The results of a study by researchers at the University of Pittsburgh and the University of Pittsburgh Medical Center suggest that the antimalarial drug hydroxychloroquine (HCQ) might also boost the … [+7099 chars]

full article...